Breast cancer · 4 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
D-FEC Variant #01 | TNBC | R 5 432 | 21d | — | — | 3 | R 16 295 PFS proxy | 1 |
TX-CEX Variant #01 | TNBC | R 5 228 | 21d | — | — | 6 | R 18 800 PFS proxy | 1 |
T-EC Variant #01 | TNBC | R 2 938 | 28d | — | — | ~12 | ~R 16 649 indirect | — |
T-AC Variant #01 | TNBC | R 1 382 | 21d | — | — | ~12 | ~R 10 425 indirect | — |
4 of 4 regimens shown